Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Based on the latest financial reports, Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.20 Million ≈ $88.66K USD) by net assets (Rs1.19 Billion ≈ $12.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Aarey Drugs & Pharmaceuticals Limited market capitalisation for the company's overall valuation and market capitalisation.

Aarey Drugs & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Aarey Drugs & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aarey Drugs & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarey Drugs & Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Explore AAREYDRUGS cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Maquia Capital Acquisition Corp NASDAQ:MAQC	0.008x
Century Lithium Corp. V:LCE	-0.005x
NPD Co. Ltd KQ:198080	0.037x
Cannindah Resources Ltd AU:CAE	-0.041x
Medico Remedies Limited NSE:MEDICO	0.009x
ORTOMA AB B F:82Y	-0.120x
Jeil Steel Mfg Co. Ltd KQ:023440	-0.047x
Dusk Group Ltd AU:DSK	-0.078x

Annual Cash Flow Conversion Efficiency for Aarey Drugs & Pharmaceuticals Limited (2009–2025)

The table below shows the annual cash flow conversion efficiency of Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. View AAREYDRUGS stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.38 Billion ≈ $14.98 Million	Rs8.95 Million ≈ $96.77K	0.006x	+128.66%
2024-03-31	Rs1.33 Billion ≈ $14.36 Million	Rs-29.94 Million ≈ $-323.77K	-0.023x	-106.66%
2023-03-31	Rs1.17 Billion ≈ $12.70 Million	Rs-12.81 Million ≈ $-138.55K	-0.011x	+72.40%
2022-03-31	Rs1.14 Billion ≈ $12.29 Million	Rs-44.93 Million ≈ $-485.90K	-0.040x	-171.37%
2021-03-31	Rs988.60 Million ≈ $10.69 Million	Rs54.77 Million ≈ $592.32K	0.055x	+79.06%
2020-03-31	Rs923.46 Million ≈ $9.99 Million	Rs28.57 Million ≈ $309.00K	0.031x	+288.83%
2019-03-31	Rs865.53 Million ≈ $9.36 Million	Rs6.89 Million ≈ $74.48K	0.008x	+103.14%
2018-03-31	Rs802.45 Million ≈ $8.68 Million	Rs-203.51 Million ≈ $-2.20 Million	-0.254x	-1427.42%
2017-03-31	Rs503.60 Million ≈ $5.45 Million	Rs9.62 Million ≈ $104.05K	0.019x	-87.61%
2016-03-31	Rs366.97 Million ≈ $3.97 Million	Rs56.59 Million ≈ $612.01K	0.154x	+67.84%
2015-03-31	Rs354.09 Million ≈ $3.83 Million	Rs32.53 Million ≈ $351.84K	0.092x	+851.96%
2014-03-31	Rs345.21 Million ≈ $3.73 Million	Rs-4.22 Million ≈ $-45.62K	-0.012x	-112.13%
2013-03-31	Rs334.70 Million ≈ $3.62 Million	Rs33.72 Million ≈ $364.71K	0.101x	+136.83%
2012-03-31	Rs328.12 Million ≈ $3.55 Million	Rs-89.76 Million ≈ $-970.74K	-0.274x	+39.84%
2011-03-31	Rs219.05 Million ≈ $2.37 Million	Rs-99.61 Million ≈ $-1.08 Million	-0.455x	-254.49%
2010-03-31	Rs92.08 Million ≈ $995.81K	Rs-11.81 Million ≈ $-127.73K	-0.128x	-3666.00%
2009-03-31	Rs83.97 Million ≈ $908.15K	Rs302.06K ≈ $3.27K	0.004x	--

About Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$31.32 Million

Rs2.90 Billion INR

Market Cap Rank

#23716 Global

#1308 in India

Share Price

Rs102.13

Change (1 day)

+0.40%

52-Week Range

Rs50.75 - Rs102.13

All Time High

Rs102.13